# Deusa Cast welcomes Colombian businessman from the cannabis sector > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/colombian-cannabis-sector-growth-global-impact/ > **Published:** 2026-04-02T19:03:49-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:31:41-04:00 > **Clinical Summary:** Explore how Colombian cannabis sector growth impacts international markets and medical cannabis supply chains worldwide. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic International MarketsSupply ChainBusiness DevelopmentMedical AccessRegulatory Why This Matters International cannabis business developments can signal evolving regulatory frameworks and supply chain opportunities that may impact patient access to standardized cannabis medicines. Colombian cannabis sector growth may influence global pricing and availability of [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/). Clinical Summary This appears to be a business podcast or media announcement featuring a Colombian cannabis industry representative. Colombia has emerged as a significant player in legal cannabis cultivation and export, with established regulatory frameworks for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) production. The country’s favorable climate and lower production costs have positioned it as a potential supplier for international [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) markets. Dr. Caplan’s Take “While business developments don’t directly change clinical practice, I watch international cannabis markets because they ultimately affect what products become available to my patients and at what cost. Colombia’s growing role could mean more diverse, affordable options down the line.” Clinical Perspective 🧠 Clinicians should monitor how international supply chain developments might affect product availability and pricing in their markets. This type of business expansion often precedes regulatory changes that can impact prescribing options. However, focus should remain on [evidence-based medicine](https://cedclinic.com/digital-health-expertise-modern-challenge/) regardless of market dynamics. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Deusa%20Cast%20welcomes%20Colombian%20businessman%20from%20the%20cannabis%20sector%20%40drcaplan&url=https%3A//sechat.com.br/en/noticia/deusa-cast-welcomes-colombian-businessman-from-the-cannabis-sector)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//sechat.com.br/en/noticia/deusa-cast-welcomes-colombian-businessman-from-the-cannabis-sector)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Deusa%20Cast%20welcomes%20Colombian%20businessman%20from%20the%20cannabis%20sector%20--%20via%20%40drcaplan.bsky.social%20https%3A//sechat.com.br/en/noticia/deusa-cast-welcomes-colombian-businessman-from-the-cannabis-sector)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://sechat.com.br/en/noticia/deusa-cast-welcomes-colombian-businessman-from-the-cannabis-sector](https://sechat.com.br/en/noticia/deusa-cast-welcomes-colombian-businessman-from-the-cannabis-sector) Table of Contents - [FAQ](#FAQ)[What type of clinical development does this represent?](#What_type_of_clinical_development_does_this_represent) - [What areas of the cannabis industry does this cover?](#What_areas_of_the_cannabis_industry_does_this_cover) - [Why is this considered clinically relevant?](#Why_is_this_considered_clinically_relevant) - [Is this related to medical or recreational cannabis?](#Is_this_related_to_medical_or_recreational_cannabis) - [How should healthcare providers use this information?](#How_should_healthcare_providers_use_this_information) - [Related](#Related) ## FAQ #### What type of clinical development does this represent? This appears to be emerging findings or policy developments in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) that warrant close monitoring. It has been assigned a clinical relevance rating of #70, indicating notable clinical interest. #### What areas of the cannabis industry does this cover? The article encompasses international markets, supply chain developments, business development initiatives, and medical access issues. These represent key sectors driving cannabis industry growth and policy changes. #### Why is this considered clinically relevant? The CED Clinical Relevance classification suggests this contains information that could impact medical cannabis practice or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). Healthcare providers should monitor these developments for potential clinical implications. #### Is this related to medical or recreational cannabis? Based on the medical access tag and clinical relevance rating, this appears to focus primarily on medical cannabis developments. However, international market changes often affect both medical and recreational sectors. #### How should healthcare providers use this information? This is classified as “emerging findings” worth monitoring closely rather than established clinical guidelines. Providers should stay informed about these developments while awaiting more definitive research or policy clarification. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Deusa Cast welcomes Colombian businessman from the cannabis sector”, “url”: “https://sechat.com.br/en/noticia/deusa-cast-welcomes-colombian-businessman-from-the-cannabis-sector”, “datePublished”: “2026-04-02T20:29:30Z”, “about”: “deusa cast welcomes colombian businessman cannabis”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [How to Start a Cannabis Business: A Complete Guide](https://cedclinic.com/cannabis-business-regulations-guide/) Learn the essential steps and regulatory considerations for launching a successful cannabis business in today's evolving market. [Start Your Cannabis Business](https://cedclinic.com/cannabis-business-regulations-guide/) [Medicinal Cannabis Export Licenses Take 6.4 Working Days In 2026 – Scoop](https://cedclinic.com/medicinal-cannabis-export-licenses-2026/) Discover the latest updates on medicinal cannabis export licensing timelines and what they mean for international trade. [Learn About Export Licensing](https://cedclinic.com/medicinal-cannabis-export-licenses-2026/) [Above and beyond: Calls to further reduce restrictions on medicinal cannabis industry](https://cedclinic.com/medicinal-cannabis-licensing-calls-to-reduce-restrictions/) Explore ongoing advocacy efforts aimed at easing regulatory barriers to expand access and innovation in medicinal cannabis. [Read About Regulatory Changes](https://cedclinic.com/medicinal-cannabis-licensing-calls-to-reduce-restrictions/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).